Literature DB >> 20961098

Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein.

Chul Won Lee1, Maria A Martinez-Yamout, H Jane Dyson, Peter E Wright.   

Abstract

The activity and stability of the tumor suppressor p53 are regulated by interactions with key cellular proteins such as MDM2 and CBP/p300. The transactivation domain (TAD) of p53 contains two subdomains (AD1 and AD2) and interacts directly with the N-terminal domain of MDM2 and with several domains of CBP/p300. Here we report the NMR structure of the full-length p53 TAD in complex with the nuclear coactivator binding domain (NCBD) of CBP. Both the p53 TAD and NCBD are intrinsically disordered and fold synergistically upon binding, as evidenced by the observed increase in helicity and increased level of dispersion of the amide proton resonances. The p53 TAD folds to form a pair of helices (denoted Pα1 and Pα2), which extend from Phe19 to Leu25 and from Pro47 to Trp53, respectively. In the complex, the NCBD forms a bundle of three helices (Cα1, residues 2066-2075; Cα2, residues 2081-2092; and Cα3, residues 2095-2105) with a hydrophobic groove into which p53 helices Pα1 and Pα2 dock. The polypeptide chain between the p53 helices remains flexible and makes no detectable intermolecular contacts with the NCBD. Complex formation is driven largely by hydrophobic contacts that form a stable intermolecular hydrophobic core. A salt bridge between D49 of p53 and R2105 of NCBD may contribute to the binding specificity. The structure provides the first insights into simultaneous binding of the AD1 and AD2 motifs to a target protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961098      PMCID: PMC2982890          DOI: 10.1021/bi1012996

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  65 in total

1.  A small domain of CBP/p300 binds diverse proteins: solution structure and functional studies.

Authors:  C H Lin; B J Hare; G Wagner; S C Harrison; T Maniatis; E Fraenkel
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

2.  Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA.

Authors:  Torsten Herrmann; Peter Güntert; Kurt Wüthrich
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

3.  Improved efficiency of protein structure calculations from NMR data using the program DIANA with redundant dihedral angle constraints.

Authors:  P Güntert; K Wüthrich
Journal:  J Biomol NMR       Date:  1991-11       Impact factor: 2.835

4.  The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.

Authors:  J J Voegel; M J Heine; M Tini; V Vivat; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

Review 5.  Assessing TP53 status in human tumours to evaluate clinical outcome.

Authors:  T Soussi; C Béroud
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

6.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

7.  Binding of p53 to the KIX domain of CREB binding protein. A potential link to human T-cell leukemia virus, type I-associated leukemogenesis.

Authors:  K Van Orden; H A Giebler; I Lemasson; M Gonzales; J K Nyborg
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

8.  Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.

Authors:  Hanqiao Feng; Lisa M Miller Jenkins; Stewart R Durell; Ryo Hayashi; Sharlyn J Mazur; Scott Cherry; Joseph E Tropea; Maria Miller; Alexander Wlodawer; Ettore Appella; Yawen Bai
Journal:  Structure       Date:  2009-02-13       Impact factor: 5.006

Review 9.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

10.  Packing, specificity, and mutability at the binding interface between the p160 coactivator and CREB-binding protein.

Authors:  Stephen J Demarest; Songpon Deechongkit; H Jane Dyson; Ronald M Evans; Peter E Wright
Journal:  Protein Sci       Date:  2004-01       Impact factor: 6.725

View more
  73 in total

1.  Is a malleable protein necessarily highly dynamic? The hydrophobic core of the nuclear coactivator binding domain is well ordered.

Authors:  Magnus Kjaergaard; Flemming M Poulsen; Kaare Teilum
Journal:  Biophys J       Date:  2012-04-03       Impact factor: 4.033

Review 2.  Fine-tuning multiprotein complexes using small molecules.

Authors:  Andrea D Thompson; Amanda Dugan; Jason E Gestwicki; Anna K Mapp
Journal:  ACS Chem Biol       Date:  2012-07-23       Impact factor: 5.100

3.  Discovery of Transcriptional Targets Regulated by Nuclear Receptors Using a Probabilistic Graphical Model.

Authors:  Mikyung Lee; Ruili Huang; Weida Tong
Journal:  Toxicol Sci       Date:  2015-12-07       Impact factor: 4.849

Review 4.  Expanding the Range of Protein Function at the Far End of the Order-Structure Continuum.

Authors:  Virginia M Burger; Diego O Nolasco; Collin M Stultz
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

5.  Mechanism and rate constants of the Cdc42 GTPase binding with intrinsically disordered effectors.

Authors:  Xiaodong Pang; Huan-Xiang Zhou
Journal:  Proteins       Date:  2016-03-09

6.  Disordered proteins follow diverse transition paths as they fold and bind to a partner.

Authors:  Jae-Yeol Kim; Hoi Sung Chung
Journal:  Science       Date:  2020-06-12       Impact factor: 47.728

7.  Expanding the proteome: disordered and alternatively folded proteins.

Authors:  H Jane Dyson
Journal:  Q Rev Biophys       Date:  2011-07-01       Impact factor: 5.318

8.  ETV4 and AP1 Transcription Factors Form Multivalent Interactions with three Sites on the MED25 Activator-Interacting Domain.

Authors:  Simon L Currie; Jedediah J Doane; Kathryn S Evans; Niraja Bhachech; Bethany J Madison; Desmond K W Lau; Lawrence P McIntosh; Jack J Skalicky; Kathleen A Clark; Barbara J Graves
Journal:  J Mol Biol       Date:  2017-07-17       Impact factor: 5.469

9.  The DNA-binding domain mediates both nuclear and cytosolic functions of p53.

Authors:  Ariele Viacava Follis; Fabien Llambi; Li Ou; Katherine Baran; Douglas R Green; Richard W Kriwacki
Journal:  Nat Struct Mol Biol       Date:  2014-05-11       Impact factor: 15.369

10.  Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.

Authors:  Peter Haberz; Munehito Arai; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Protein Sci       Date:  2016-10-15       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.